Common use of Program Intellectual Property Clause in Contracts

Program Intellectual Property. Genethon hereby grants to Audentes an exclusive (including as to Genethon), royalty-free, fully paid-up, worldwide, sublicenseable license under Genethon’s interest in any Program Intellectual Property for the purpose of making, using, importing, selling, offering for sale and otherwise discovering, researching, developing or commercializing Products.

Appears in 2 contracts

Sources: Collaborative Development Agreement (Audentes Therapeutics, Inc.), Collaborative Development Agreement (Audentes Therapeutics, Inc.)